A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- Annual Rutgers Health Faculty Development Symposium – TOMORROW 6/19
- Losing weight in middle age could reduce chronic diseases later, study shows.
- Weill Cornell-Rutgers Health NeuroHIV Research Symposium II on July 8th
- Rutgers University research continues to put New Jersey on the map.
- Are synthetic food dyes unsafe? Experts reveal what the research really shows.
Categories
- Community (2,284)
- Covid (987)
- CTO Events (6)
- News (2,909)
- Pilots (21)